Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - Global Medical REIT Inc.Financial_Report.xls

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 10-K

Amendment No. 1


  X .ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended August 31, 2014


or


      .TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from __________ to __________


Commission File Number: 333-177592


Global Medical REIT Inc.

(Exact name of registrant as specified in its charter)


Maryland

 

46-4757266

(State or other jurisdiction of incorporation or organization)

 

(I.R.S. Employer Identification No.)

 

 

 

4800 Montgomery Lane #450,

Bethesda, MD

 

20814

(Address of principal executive offices)

 

(Zip Code)


Registrant’s telephone number, including area code: 202-524-6851


Securities registered pursuant to Section 12(b) of the Act: None


Securities registered pursuant to Section 12(g) of the Act: None


Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes      . No  X ..


Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes      . No  X .


Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  X .  No      .


Indicate by a check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§229.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes  X .  No      .


Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§229.405 of this chapter) is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.  X .


Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See the definitions of “large accelerated filer”, “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act (check one).


Large accelerated filer

      .

Accelerated filer

      .

Non-accelerated filer

      . (Do not check if a smaller reporting company)

Smaller reporting company

  X .


Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes      .  No  X .



31




As of the last business day of the registrant’s most recently completed third fiscal quarter, there was no active public trading market for the registrant’s common stock.


State the aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was sold as of the last business day of the registrant’s most recently completed second fiscal quarter: $0 on February 28, 2014


As of December 12, 2014, there were 250,000 shares the registrant’s common stock, par value of $0.001 per share outstanding.


DOCUMENTS INCORPORATED BY REFERENCE


None.




32



EXPLANATORY NOTE

 

The purpose of this Amendment No. 1 to Global Medical REIT, Inc.'s Annual Report on Form 10-K for the period ended August 31, 2014, filed with the Securities and Exchange Commission on December 16, 2014 (the “Form 10-K”), is solely to furnish Exhibit 101 to the Form 10-K in accordance with Rule 405 of Regulation S-T. Exhibit 101 to this report provides the consolidated financial statements and related notes from the Form 10-K formatted in XBRL (eXtensible Business Reporting Language).

 

No other changes have been made to the Form 10-K. This Amendment No. 1 to the Form 10-K speaks as of the original filing date of the Form 10-K, does not reflect events that may have occurred subsequent to the original filing date, and does not modify or update in any way disclosures made in the original Form 10-K.

 

Pursuant to Rule 406T of Regulation S-T, the interactive data files on Exhibit 101 hereto are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, are deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and otherwise are not subject to liability under those sections.



33





PART III


ITEM 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES


Exhibit No.

 

Description

101.INS

 

XBRL Instance Document

101.SCH

 

XBRL Taxonomy Schema

101.CAL

 

XBRL Taxonomy Calculation Linkbase

101.DEF

 

XBRL Taxonomy Definition Linkbase

101.LAB

 

XBRL Taxonomy Label Linkbase

101.PRE

 

XBRL Taxonomy Presentation Linkbase


Filed herewith


XBRL (Extensible Business Reporting Language) information is furnished and not filed or a part of this Annual Report on Form 10-K for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, is deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and otherwise is not subject to liability under these sections.



34




SIGNATURES


Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


 

Global Medical REIT Inc.

 

 

 

 

 

 

 

 

 

Dated: December 18, 2014

By:

/s/ David A. Young

 

 

David A. Young

 

 

Chief Executive Officer (Principal Executive Officer)


Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities indicated and on the date indicated.


Signature

 

Title

 

Date

 

 

 

 

 

/s/ David A. Young

 

Chief Executive Officer and Director (principal executive officer)

 

December 18, 2014

David A. Young

 

 

 

 

 

 

 

 

 

/s/ Donald McClure

 

Chief Financial Officer (principal financial and accounting officer)

 

December 18, 2014

Donald McClure

 

 

 

 

 

 

 

 

 

/s/ Conn Flanigan

 

Secretary and Director

 

December 18, 2014

Conn Flanigan

 

 

 

 

 

 

 

 

 

/s/ Jeffrey Busch

 

Director

 

December 18, 2014

Jeffrey Busch

 

 

 

 

 

 

 

 

 

/s/ Fai H. Chan

 

Director

 

December 18, 2014

Fai H. Chan

 

 

 

 

 

 

 

 

 

/s/ Tong Wan Chan

 

Director

 

December 18, 2014

Tong Wan Chan

 

 

 

 




35